Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 69 positions · Total reported value $2.38B · Top-10 concentration 53.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, Sofinnova Investments, Inc. disclosed 69 equity positions with a combined reported value of $2.38B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were NTRA ($310.04M), IWM ($148.80M), XBI ($134.12M). By sector, the heaviest allocations are Health Care 81.1%, Other 18.9%. Versus the prior quarter, allocation shifted toward Other (+11.2pp) and away from Health Care (-11.2pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 54% of names.

The largest new positions opened in Q1 2026 were IWM ($148.80M), XBI ($134.12M), QQQ ($86.58M).

Of the 26 positions fully exited versus the prior quarter, the largest were VRTX ($74.62M), ABBV ($72.61M), ISRG ($71.91M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • IWM ISHARES TR · $148.80M
  • XBI SPDR SERIES TRUST · $134.12M
  • QQQ INVESCO QQQ TR · $86.58M
  • IBB ISHARES TR · $80.20M
  • BIIB BIOGEN INC · $42.08M
  • PFE PFIZER INC · $22.46M
  • GMAB GENMAB A/S · $20.18M
  • LQDA LIQUIDIA CORPORATION · $18.87M

Fully Exited (vs previous quarter)

  • VRTX VERTEX PHARMACEUTICALS INC · prev qtr: $74.62M
  • ABBV ABBVIE INC · prev qtr: $72.61M
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $71.91M · history
  • LLY ELI LILLY & CO · prev qtr: $66.26M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $53.75M
  • APGE APOGEE THERAPEUTICS INC · prev qtr: $40.37M
  • CDTX CIDARA THERAPEUTICS INC · prev qtr: $39.82M
  • GKOS GLAUKOS CORP · prev qtr: $32.53M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.1%
Other 18.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.55M $310.04M 13.02%
13.02%
Hold
2 600.00K $148.80M 6.25%
6.25%
New
3 1.05M $134.12M 5.63%
5.63%
New
4 1.99M $120.62M 5.06%
5.06%
Add
5 598.33K $113.11M 4.75%
4.75%
Reduce
6 2.79M $112.40M 4.72%
4.72%
Hold
7 456.03K $89.94M 3.78%
3.78%
Reduce
8 150.00K $86.58M 3.63%
3.63%
New
9 2.11M $81.35M 3.42%
3.42%
Add
10 475.00K $80.20M 3.37%
3.37%
New
11 1.90M $59.59M 2.50%
2.50%
Hold
12 346.07K $56.59M 2.38%
2.38%
Add
13 729.97K $55.00M 2.31%
2.31%
Add
14 954.31K $49.33M 2.07%
2.07%
Add
15 80.30K $47.62M 2.00%
2.00%
Reduce
16 781.98K $44.17M 1.85%
1.85%
Add
17 229.52K $42.08M 1.77%
1.77%
New
18 2.29M $40.12M 1.68%
1.68%
Hold
19 450.10K $39.14M 1.64%
1.64%
Add
20 1.70M $39.14M 1.64%
1.64%
Hold
21 1.13M $37.71M 1.58%
1.58%
Add
22 1.70M $37.22M 1.56%
1.56%
Add
23 509.55K $36.66M 1.54%
1.54%
Add
24 3.63M $35.72M 1.50%
1.50%
Add
25 300.00K $34.24M 1.44%
1.44%
Hold
26 200.00K $33.80M 1.42%
1.42%
Add
27 409.18K $30.39M 1.28%
1.28%
Reduce
28 1.63M $29.62M 1.24%
1.24%
Reduce
29 406.03K $27.30M 1.15%
1.15%
Reduce
30 393.58K $24.72M 1.04%
1.04%
Add
31 818.33K $23.12M 0.97%
0.97%
Add
32 800.00K $22.46M 0.94%
0.94%
New
33 63.68K $20.52M 0.86%
0.86%
Reduce
34 752.26K $20.18M 0.85%
0.85%
New
35 923.09K $19.94M 0.84%
0.84%
Reduce
36 500.00K $18.87M 0.79%
0.79%
New
37 305.22K $17.75M 0.74%
0.74%
Add
38 44.48K $14.62M 0.61%
0.61%
New
39 248.25K $13.77M 0.58%
0.58%
Reduce
40 478.00K $13.24M 0.56%
0.56%
Reduce
41 386.50K $12.17M 0.51%
0.51%
Reduce
42 251.50K $10.79M 0.45%
0.45%
New
43 679.58K $8.61M 0.36%
0.36%
New
44 395.08K $8.27M 0.35%
0.35%
New
45 204.01K $7.81M 0.33%
0.33%
New
46 1.02M $7.77M 0.33%
0.33%
New
47 350.00K $7.33M 0.31%
0.31%
Add
48 210.66K $6.98M 0.29%
0.29%
New
49 344.17K $6.50M 0.27%
0.27%
New
50 91.79K $6.05M 0.25%
0.25%
New

FAQ

What did Sofinnova Investments, Inc. buy in 2026-Q1?

In its 2026-Q1 13F filing, Sofinnova Investments, Inc. reported 69 equity positions worth $2.38B in aggregate; its largest disclosed positions were NTRA ($310.04M), IWM ($148.80M), XBI ($134.12M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $2.38B of long equity holdings across 69 positions as of 2026-Q1. Top-10 holdings account for 53.6% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →